Journal of the American Chemical Society
Article
installed by a novel one-pot two-step procedure and it was
found that protection of the 1,2-diol facilitated modification of
the C-3, C-4, and C-6 alcohols. The resulting 1,2-oxathianes
could be employed as glycosyl donors for highly selective 1,2-
cis-glycosylation by oxidation to sulfoxides followed by arylation
with 1,3,5-trimethoxybenzene to give a bicyclic anomeric
sulfonium ion. The attractiveness of the new building blocks
has been demonstrated by the preparation of a biologically
important branched α-glucan, which was assembled by a latent-
active glycosylation strategy.
assignment and conformational analysis of diastereomeric
sulfonium ions, control glycosylations using donors without
C-2 auxiliary, copies of 1H and 13C NMR spectra. This material
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
EXPERIMENTAL SECTION
Full experimental is available in Supporting Information. Compounds
1,18 24,36 25,37 26,38 27,39 34,15 35,15 and 3740 were prepared
following literature procedures.
ACKNOWLEDGMENTS
■
■
We thank Dr. John Glushka for assisting with NMR
experiments and Dr. Paul von Rague Schleyer for helpful
discussions. The research was supported by the National
Institute of General Medical Sciences (NIGMS) of the U.S.
National Institutes of Health (R01GM065248, G.-J.B.).
General Procedure for the Preparation of Sulfoxide Donors
17−23 from their Corresponding Oxathianes 9−11 and 13−
16. m-CPBA (≤77%, l.1 equiv) was dissolved in DCM and slowly
injected into a cooled (−78 °C) solution of oxathiane in DCM. The
mixture was stirred at −78 °C for 30 min, diluted with DCM (50 mL)
and then poured into 10% Na2S2O3 aqueous solution. The organic
layer was washed with saturated NaHCO3, dried (MgSO4), filtered,
and the filtrate was concentrated in vacuo. The residue was purified by
silica gel chromatography.
General Glycosylation Procedure for Oxathiane Donors with
Various Acceptors. A mixture of sulfoxide donor (1 equiv), 1,3,5-
trimethoxybenzene (1.5 equiv), 2,6-di-tert-butyl-4-methyl pyridine (2
equiv), and activated molecular sieves (4 Å) in DCM (adjusted donor
concentration to 0.15 M) was stirred for 1 h under an atmosphere of
argon. After cooling to −10 °C, trifluoromethanesulfonic anhydride
(1.1 equiv) was added. After 30 min, the reaction mixture was cooled
(−40 °C), and a solution of acceptor (0.8 equiv) in DCM (adjusted
donor concentration to 0.1 M) was added slowly. The temperature of
the reaction mixture was kept at −40 °C for another 60 min before
allowed to warm to room temperature. After 15 h, the reaction mixture
was diluted with DCM (10 mL), filtered, and the filtrate was
concentrated in vacuo. The residue was purified by silica gel column
chromatography or sephadex LH20 size exclusion chromatography
(DCM/MeOH = 1:1, 0.2 mL/min).
General Procedure for the Removal of C-2 Auxiliary.
Trifluoroacetic acid was added dropwise to a solution of glucoside
in DCM at 0 °C adjusting the final concentration to 10% (v/v). The
reaction mixture was stirred for 0.5−3 h until TLC indicated complete
consumption of starting material. The reaction mixture was diluted
with DCM and poured into saturated NaHCO3. The organic layer was
dried (MgSO4) and filtered, and the filtrate was concentrated in vacuo.
The residue was purified by silica gel column chromatography.
Procedures for NMR Study of Sulfonium ions. S-(2,3,5-
Trimethoxylphenyl)oxathianium triflate: a mixture of R/S sulfoxides
(10 μmol), 1,3,5-trimethoxybenzene (16 μmol), 2,6-di-tert-butyl-4-
methyl pyridine (21 μmol), and activated molecular sieves (4 Å,
pellets) in CDCl3 (1 mL) was shaken for 30 min under an atmosphere
of argon. Then 0.5 mL of the solution was transferred to a 5 mm NMR
tube and sealed. After cooling to 0 °C, a trifluoromethanesulfonic
anhydride stock solution (25 μL, 0.23 M in CDCl3) was added and
NMR spectra for 55−58 were recorded at room temperature. S-
Methyl-oxathianium triflate: Sulfide (10 μmol) was dissolved in dry
CDCl3 (1 mL), methyl triflate (0.1 mmol) was added under the
atmosphere of argon at room temperature. The reaction mixture was
stirred for 2−16 h and monitored by TLC. After the consumption of
sulfide, 0.5 mL of the reaction mixture was transferred to a 5 mm
NMR tube and sealed. NMR spectra for 59−61 were recorded at
room temperature.
REFERENCES
■
(1) Brockhausen, I. EMBO Rep. 2006, 7, 599−604. Ohtsubo, K.;
Marth, J. D. Cell 2006, 126, 855−867. Slawson, C.; Hart, G. W. Nat.
Rev. Cancer 2011, 11, 678−684.
(2) Crocker, P. R.; Paulson, J. C.; Varki, A. Nat. Rev. Immunol. 2007,
7, 255−266. van Vliet, S. J.; Garcia-Vallejo, J. J.; van Kooyk, Y.
Immunol. Cell Biol. 2008, 86, 580−587. Astronomo, R. D.; Burton, D.
R. Nat. Rev. Drug Discovery 2010, 9, 308−324. Morelli, L.; Poletti, L.;
Lay, L. Eur. J. Org. Chem. 2011, 5723−5777.
(3) Montesano, M.; Brader, G.; Palva, E. T. Mol. Plant Pathol. 2003,
4, 73−79. Silipo, A.; Erbs, G.; Shinya, T.; Dow, J. M.; Parrilli, M.;
Lanzetta, R.; Shibuya, N.; Newman, M. A.; Molinaro, A. Glycobiology
2010, 20, 406−419.
(4) Brown, J. R.; Crawford, B. E.; Esko, J. D. Crit. Rev. Biochem. Mol.
Biol. 2007, 42, 481−515. Liang, P. H.; Wu, C. Y.; Greenberg, W. A.;
Wong, C. H. Curr. Opin. Chem. Biol. 2008, 12, 86−92. Buskas, T.;
Thompson, P.; Boons, G. J. Chem. Commun. 2009, 5335−5349. Ernst,
B.; Magnani, J. L. Nat. Rev. Drug Discovery 2009, 8, 661−677.
Laremore, T. N.; Zhang, F.; Dordick, J. S.; Liu, J.; Linhardt, R. J. Curr.
Opin. Chem. Biol. 2009, 13, 633−640. Stallforth, P.; Lepenies, B.;
Adibekian, A.; Seeberger, P. H. J. Med. Chem. 2009, 52, 5561−5577.
(5) Zhu, X. M.; Schmidt, R. R. Angew. Chem., Int. Ed. 2009, 48,
1900−1934. Schmaltz, R. M.; Hanson, S. R.; Wong, C. H. Chem. Rev.
2011, 111, 4259−4307.
(6) Boltje, T. J.; Buskas, T.; Boons, G. J. Nature Chem. 2009, 1, 611−
622.
(7) Wong, C. H.; Ye, X. S.; Zhang, Z. J. Am. Chem. Soc. 1998, 120,
7137−7138. Zhu, T.; Boons, G. J. Tetrahedron: Asymmetry 2000, 11,
199−205. Werz, D. B.; Ranzinger, R.; Herget, S.; Adibekian, A.; von
der Lieth, C. W.; Seeberger, P. H. ACS Chem. Biol. 2007, 2, 685−691.
Arungundram, S.; Al-Mafraji, K.; Asong, J.; Leach, F. E., 3rd; Amster, I.
J.; Venot, A.; Turnbull, J. E.; Boons, G. J. J. Am. Chem. Soc. 2009, 131,
17394−17405. Adibekian, A.; Stallforth, P.; Hecht, M. L.; Werz, D. B.;
Gagneux, P.; Seeberger, P. H. Chem. Sci. 2011, 2, 337−344.
(8) Demchenko, A. V. Curr. Org. Chem. 2003, 7, 35−79. Cai, F.; Wu,
B.; Crich, D. Adv. Carbohydr. Chem. Biochem. 2009, 62, 251−309. Guo,
J.; Ye, X. S. Molecules 2010, 15, 7235−7265.
(9) Boons, G. J. Tetrahedron 1996, 52, 1095−1121. Codee, J. D. C.;
Litjens, R.; van den Bos, L. J.; Overkleeft, H. S.; van der Marel, G. A.
Chem. Soc. Rev. 2005, 34, 769−782. Tanaka, H.; Yamada, H.;
Takahashi, T. Trends Glycosci. Glycotechnol. 2007, 19, 183−193.
(10) Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Science 2001, 291,
1523. Seeberger, P. H. Chem. Soc. Rev. 2008, 37, 19−28.
(11) Imamura, A.; Ando, H.; Korogi, S.; Tanabe, G.; Muraoka, O.;
Ishida, H.; Kiso, M. Tetrahedron Lett. 2003, 44, 6725−6728.
(12) Zhu, X. M.; Kawatkar, S.; Rao, Y.; Boons, G. J. J. Am. Chem. Soc.
2006, 128, 11948−11957.
ASSOCIATED CONTENT
■
S
* Supporting Information
Full experimental procedures and characterizations of prepared
compounds, detailed NMR analysis of sulfonium ion 55,
(13) Kim, J. H.; Yang, H.; Park, J.; Boons, G. J. J. Am. Chem. Soc.
2005, 127, 12090−12097.
7551
dx.doi.org/10.1021/ja3018187 | J. Am. Chem. Soc. 2012, 134, 7545−7552